November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Shearwood McClelland III: Financial Toxicity associated with achieving PFS based on the INDIGO trial
Aug 16, 2024, 19:37

Shearwood McClelland III: Financial Toxicity associated with achieving PFS based on the INDIGO trial

Shearwood McClelland III, Director of Spine Oncology, Department of Radiation Oncology at University Hospitals, shared a post on X about his recent paper, commenting:

“Pleased to publish our piece regarding the Financial Toxicity associated with achieving progression-free survival based on the INDIGO trial with Michael Milano and Martin Tom!”

The Cost of Progression-Free Survival in Treating Low-Grade Glioma published in American Journal of Clinical Oncology.

Authors: Shearwood McClelland III, Martin C. Tom, Michael T. Milano.

Shearwood McClelland III

 

Additional information
Source: Shearwood McClelland III/X